A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : OI / optical imaging

[Related PubMed/MEDLINE]
Total Number of Papers: 65
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   OI  (>> Co-occurring Abbreviation)
Long Form:   optical imaging
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Comparative immuno-Cerenkov luminescence and -PET imaging enables detection of PSMA+ tumors in mice using 64Cu-radiolabeled monoclonal antibodies. immuno-CLI, PET, PSMA
2019 Indocyanine green labeling for optical and photoacoustic imaging of mesenchymal stem cells after in vivo transplantation. FDA, ICG, MSCs, NIRF, PAI
2019 Microwave-Synthesized Platinum-Embedded Mesoporous Silica Nanoparticles as Dual-Modality Contrast Agents: Computed Tomography and Optical Imaging. CT, ICP-MS, MSNs, NIR, nPtNPs, PEG-MSNs-Pt-Dy800
2019 Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs). ECM, MMPIs, MMPIs, MMPs, PET, SPECT
2019 State of the Art of Natural Killer Cell Imaging: A Systematic Review. MRI, NK
2019 Targeted 64 Cu-labeled gold nanoparticles for dual imaging with positron emission tomography and optical imaging. CT, PET
2017 Developing Targeted Hybrid Imaging Probes by Chelator Scaffolding. CCK2R, FSC, PET
2017 Multifunctional Gadolinium-Doped Mesoporous TiO2 Nanobeads: Photoluminescence, Enhanced Spin Relaxation, and Reactive Oxygen Species Photogeneration, Beneficial for Cancer Diagnosis and Treatment. MRI, NBs, ROS
2017 Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent. CHR, DTHRs, MMP, NIR, RA
10  2017 Pyramid approach for the reduction of parallax-related artefacts in optical recordings of moving translucent volumes. DOF, VSD
11  2017 State of the art in vivo imaging techniques for laboratory animals. CT, MRI, PET, SPECT, US
12  2016 Compensation of pulsation artifacts during optical imaging with and without cranial chamber. ---
13  2016 Fluorescence and Cerenkov luminescence imaging. Applications in small animal research. CLI
14  2016 Implementation of a Quality Improvement Bundle Improves Echocardiographic Imaging after Congenital Heart Surgery in Children. OR
15  2016 Motion invariant contrast enhancement of optical imaging data in the gradient domain. EEG-OI, SNR, VSD
16  2016 Multimodal molecular imaging system for pathway-specific reporter gene expression. fluc, hFTH, LiCl, MRI
17  2015 Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery. NPs
18  2015 Assembly of near infra-red emitting upconverting nanoparticles and multiple Gd(III)-chelates as a potential bimodal contrast agent for MRI and optical imaging. DOTA, MRI
19  2015 Harnessing medically relevant metals onto water-soluble subphthalocyanines: towards bimodal imaging and theranostics. SubPc
20  2015 Negative hemodynamic response in the cortex: evidence opposing neuronal deactivation revealed via optical imaging and electrophysiological recording. MEA, NHR, PHR
21  2015 Polymer-doxycycline conjugates as fibril disrupters: an approach towards the treatment of a rare amyloidotic disease. DOXY, FAP, PGA, PNS, TTR
22  2014 A bis(pyridine N-oxide) analogue of DOTA: relaxometric properties of the Gd(III) complex and efficient sensitization of visible and NIR-emitting lanthanide(III) cations including Pr(III) and Ho(III). anti-SAP
23  2014 Bimodal imaging probes for combined PET and OI: recent developments and future directions for hybrid agent development. PET
24  2014 Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging. AKI, EVs, i.v, MSCs, NIR
25  2014 Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging. DFO, PET
26  2014 Multimodality imaging probe for positron emission tomography and fluorescence imaging studies. biotin-NHSI, BSA, DTPA, MALDI, PET
27  2014 PET/MR imaging and optical imaging of metastatic rhabdomyosarcoma in mice. ---
28  2014 Preclinical imaging: an essential ally in modern biosciences. CT, MRI, MRSI, PET, SPECT
29  2014 Targeted fluorescent magnetic nanoparticles for imaging of human breast cancer. MRI, T2W
30  2014 U-SPECT-BioFluo: an integrated radionuclide, bioluminescence, and fluorescence imaging platform. BLI, SPECT
31  2014 Visualization, imaging and new preclinical diagnostics in radiation oncology. CT, MRI, PET
32  2013 Multimodality molecular imaging of stem cells therapy for stroke. BBB, MRI
33  2013 Non-invasive imaging for studying anti-angiogenic therapy effects. CT, MRI, PAI, PET, SPECT, US
34  2013 Noninvasive optical imaging of nanomedicine biodistribution. muCT
35  2012 Cerenkov Luminescence Imaging (CLI) for cancer therapy monitoring. CLI, CR, PET
36  2011 A new model of rectal cancer with regional lymph node metastasis allowing in vivo evaluation by imaging biomarkers. MRI, TARCI
37  2011 A shift from cell cultures to creatures: in vivo imaging of small animals in experimental regenerative medicine. CT, MRI, PET, US
38  2011 Combined Cerenkov luminescence and nuclear imaging of radioiodine in the thyroid gland and thyroid cancer cells expressing sodium iodide symporter: initial feasibility study. ARO-NIS, CLI, NI, RI
39  2011 Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarction. DiD, IM, MI, MRI, MSCs
40  2011 Hemodynamic observation and spike recording explain the neuronal deactivation origin of negative response in rat. MEA, NHR, PHR
41  2011 In vivo ⁸F-FDG tumour uptake measurements in small animals using Cerenkov radiation. CCD, CR
42  2011 Labeling human mesenchymal stem cells with fluorescent contrast agents: the biological impact. GAG, hMSC, MR
43  2011 Optical imaging in vivo with a focus on paediatric disease: technical progress, current preclinical and clinical applications and future perspectives. NIR, OCT
44  2011 Optical imaging of rheumatoid arthritis. ---
45  2011 Optical imaging of Tc-99m-based tracers: in vitro and in vivo results. ---
46  2010 Cerenkov radiation allows in vivo optical imaging of positron emitting radiotracers. CCD, CR, PET
47  2010 In vivo magnetic resonance imaging and optical imaging comparison of viable and nonviable mesenchymal stem cells with a bifunctional label. MRI, MSCs
48  2010 Labeling human embryonic stem cell-derived cardiomyocytes with indocyanine green for noninvasive tracking with optical imaging: an FDA-compatible alternative to firefly luciferase. hESC-CMs, ICG
49  2010 Molecular optical imaging with radioactive probes. ---
50  2010 Mouse models in neurological disorders: applications of non-invasive imaging. MI, MRI, PET
51  2010 OI and fMRI signal separation using both temporal and spatial autocorrelations. BSS, CCA, fMRI, LD-CCA, SIP, tICA
52  2010 Optical imaging of reporter gene expression using a positron-emission-tomography probe. HSV1-tk, PET
53  2010 Optical techniques for the molecular imaging of angiogenesis. NIR
54  2009 An optical imaging method to monitor stem cell migration in a model of immune-mediated arthritis. MSC
55  2009 Optical imaging of cellular immunotherapy against prostate cancer. EpCAM, NK
56  2009 Optical imaging of the peri-tumoral inflammatory response in breast cancer. ---
57  2009 Whole body optical imaging in small animals and its translation to the clinic: intra-operative optical imaging guided surgery. BLI, CCCD, FLI, GFP, Luc, RFP
58  2008 Cell tracking with optical imaging. ---
59  2008 Detection of postoperative granulation tissue with an ICG-enhanced integrated OI-/X-ray System. ICG
60  2008 Improved fluorescence of indocyanine green in vitro and in vivo after simple cooling procedures. ICG
61  2008 Labeling stem cells with fluorescent dyes for non-invasive detection with optical imaging. hESC, hMSC, ICG
62  2008 Refinement and reduction in animal experimentation: options for new imaging techniques. PET
63  2007 Functional imaging of cancer with emphasis on molecular techniques. CT, MRI, PET, SPECT, US
64  2004 Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy. MR, SNR
65  2004 Optical imaging of intrinsic signals: recent developments in the methodology and its applications. ---